# Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders

> **NCT03036293** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 390 (actual)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Tenoten
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03036293
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2018-09-22
- **Final completion:** 2018-09-22
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2020-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036293, "Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03036293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*